Cargando…
Patient‐derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment
Pseudomyxoma peritonei (PMP) is a neoplastic syndrome characterized by peritoneal tumor implants with copious mucinous ascites. The standard of care for PMP patients is aggressive cytoreductive surgery performed in conjunction with heated intraperitoneal chemotherapy. Not all patients are candidates...
Autores principales: | Kuracha, Murali R., Thomas, Peter, Loggie, Brian W., Govindarajan, Venkatesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831290/ https://www.ncbi.nlm.nih.gov/pubmed/26833741 http://dx.doi.org/10.1002/cam4.640 |
Ejemplares similares
-
Pseudomyxoma Peritonei
por: Homeag, Maria, et al.
Publicado: (2009) -
Pseudomyxoma peritonei: An uncommon tumor
por: Gupta, Surabhi, et al.
Publicado: (2010) -
Approach to pseudomyxoma peritonei
por: Rizvi, Syed Ali, et al.
Publicado: (2018) -
Molecular profiles of high‐grade and low‐grade pseudomyxoma peritonei
por: Noguchi, Rei, et al.
Publicado: (2015) -
Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies
por: Kuracha, Murali R., et al.
Publicado: (2017)